Search

everythinglearnresearchcommunity

for

Search:↓

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

More research is needed to find the best long-term treatments for Alopecia Areata.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

Surface-modified nanostructured lipid carriers can improve hair growth treatments.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Finasteride's potential harms are hard to accurately measure.

Many patients with autoimmune blistering skin disorders change their diets, avoiding foods like alcohol, citrus, and spices, and some find vegetables and dairy helpful.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Genes controlling hair growth and immune response are disrupted in male pattern baldness.

The document concludes that PK/PD modeling is important for determining the safe and effective dosages of drugs.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Dutasteride safely promotes hair growth and reduces hair loss, with mild side effects.

Dupilumab for skin problems might reactivate hair loss in some patients.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Deleting the Trf1 protein in mice is safe and may help prevent cancer without major side effects.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.